Mraz Amerine & Associates Inc. Has $1.04 Million Stock Holdings in Nutrien Ltd. (NYSE:NTR)

Mraz Amerine & Associates Inc. boosted its stake in Nutrien Ltd. (NYSE:NTR) by 8.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 18,535 shares of the company’s stock after purchasing an additional 1,369 shares during the quarter. Mraz Amerine & Associates Inc.’s holdings in Nutrien were worth $1,044,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Vanguard Group Inc. grew its holdings in shares of Nutrien by 1.9% during the third quarter. Vanguard Group Inc. now owns 18,052,214 shares of the company’s stock valued at $1,114,905,000 after buying an additional 332,190 shares during the last quarter. Deutsche Bank AG grew its holdings in shares of Nutrien by 1.5% during the third quarter. Deutsche Bank AG now owns 14,708,135 shares of the company’s stock valued at $908,374,000 after buying an additional 214,299 shares during the last quarter. Mackenzie Financial Corp grew its holdings in shares of Nutrien by 1.8% during the fourth quarter. Mackenzie Financial Corp now owns 13,331,450 shares of the company’s stock valued at $751,381,000 after buying an additional 239,578 shares during the last quarter. Parnassus Investments LLC grew its holdings in shares of Nutrien by 1.3% during the third quarter. Parnassus Investments LLC now owns 10,057,019 shares of the company’s stock valued at $621,121,000 after buying an additional 131,418 shares during the last quarter. Finally, First Eagle Investment Management LLC boosted its holdings in Nutrien by 0.5% during the third quarter. First Eagle Investment Management LLC now owns 9,262,659 shares of the company’s stock worth $572,062,000 after purchasing an additional 48,230 shares during the last quarter. 63.10% of the stock is currently owned by institutional investors and hedge funds.

Nutrien Price Performance

NYSE:NTR traded up $0.14 during mid-day trading on Wednesday, hitting $51.81. 1,252,589 shares of the stock traded hands, compared to its average volume of 2,051,746. The business’s 50-day moving average price is $52.80 and its 200 day moving average price is $54.39. The company has a market cap of $25.62 billion, a PE ratio of 20.42, a price-to-earnings-growth ratio of 1.91 and a beta of 0.89. Nutrien Ltd. has a 12-month low of $47.90 and a 12-month high of $75.29. The company has a quick ratio of 0.65, a current ratio of 1.17 and a debt-to-equity ratio of 0.35.

Nutrien (NYSE:NTR) last issued its quarterly earnings data on Wednesday, February 21st. The company reported $0.37 EPS for the quarter, missing the consensus estimate of $0.72 by ($0.35). Nutrien had a net margin of 4.33% and a return on equity of 8.59%. The firm had revenue of $5.66 billion for the quarter, compared to analysts’ expectations of $5.36 billion. During the same period in the prior year, the firm posted $2.02 EPS. Nutrien’s revenue was down 24.8% on a year-over-year basis. On average, analysts expect that Nutrien Ltd. will post 3.91 EPS for the current fiscal year.

Nutrien Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, April 11th. Shareholders of record on Thursday, March 28th were paid a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 4.17%. The ex-dividend date was Wednesday, March 27th. This is a boost from Nutrien’s previous quarterly dividend of $0.53. Nutrien’s payout ratio is currently 85.38%.

Analysts Set New Price Targets

NTR has been the topic of several analyst reports. TD Securities cut their price target on shares of Nutrien from $75.00 to $67.00 and set a “buy” rating on the stock in a report on Tuesday, February 20th. Raymond James lowered shares of Nutrien from an “outperform” rating to a “market perform” rating and lowered their price objective for the stock from $80.00 to $65.00 in a research report on Friday, January 12th. BMO Capital Markets lowered their price objective on shares of Nutrien from $86.00 to $80.00 and set an “outperform” rating on the stock in a research report on Thursday, January 25th. HSBC lowered their price objective on shares of Nutrien from $63.00 to $57.00 and set a “hold” rating on the stock in a research report on Friday, March 8th. Finally, CIBC lowered their price objective on shares of Nutrien from $87.00 to $76.00 and set an “outperform” rating on the stock in a research report on Friday, February 23rd. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $67.95.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.